Table 1 Baseline characteristics of patients at ICU admission
All population (n = 177) | Clinical failure (n = 52) | Clinical cure (n = 125) | p | ||||
|---|---|---|---|---|---|---|---|
Nb | Results | Nb | Results | Nb | Results | ||
Gender (male) | 177 | 134 (75.7%) | 52 | 42 (80.8%) | 125 | 92 (73.6%) | 0.311 |
Age (years) | 177 | 64 (50–70) | 52 | 65 (50–70) | 125 | 64 (50–71) | 0.928 |
Past medical history | |||||||
Hospitalization during the last 12 months | 175 | 72 (41.1%) | 52 | 21 (40.4%) | 123 | 51 (41.5%) | 0.895 |
Hospitalization delay (months) | 74 | 1 (1–2) | 21 | 1 (1–3) | 53 | 1 (1–1) | 0.03 |
ATBs during the last 3 months | 166 | 31 (18.7%) | 49 | 9 (18.4%) | 117 | 22 (18.8%) | 0.948 |
Immunosuppression | 177 | 61 (34.5%) | 52 | 14 (26.9%) | 125 | 47 (37.6%) | 0.173 |
Corticosteroids | 61 | 50 (82%) | 14 | 12 (85.7%) | 47 | 38 (80.9%) | 0.678 |
Immunosuppressive therapy | 61 | 10 (16.4%) | 14 | 2 (14.3%) | 47 | 8 (17%) | 0.808 |
Hemopathy | 61 | 1 (1.6%) | 14 | 0 (0%) | 47 | 1 (2.1%) | 0.582 |
Extravascular device | 177 | 7 (4%) | 52 | 2 (3.8%) | 125 | 5 (4%) | 0.962 |
Endovascular device | 177 | 40 (22.6%) | 52 | 9 (17.3%) | 125 | 31 (24.8%) | 0.278 |
Diabetes mellitus | 177 | 46 (26%) | 52 | 17 (32.7%) | 125 | 29 (23.2%) | 0.19 |
McCabe score | 176 | 1 (0–2) | 51 | 1 (0–2) | 125 | 1 (0–2) | 0.933 |
Delay from hospitalization to ICU (days) | 174 | 0 (0–1) | 50 | 0 (0–1) | 124 | 0 (0–0) | 0.408 |
ICU | |||||||
Surgery at admission | 176 | 57 (32.4%) | 52 | 16 (30.8%) | 124 | 41 (33.1%) | 0.767 |
Infection at admission | 175 | 69 (39.4%) | 51 | 17 (33.3%) | 124 | 52 (41.9%) | 0.29 |
SAPS II score | 140 | 37 (27–49) | 42 | 37 (27–54) | 98 | 37.5 (27–49) | 0.747 |
SOFA score at admission | 131 | 6 (3–8) | 41 | 5 (3–8) | 90 | 7 (3–8) | 0.972 |